auto-immune

Posted by Cort Johnson

It doesn’t always take a village; sometimes it just takes a committed few to possibly change the future of a disorder; in this case, it may come down to just thirty patients and two researchers in Norway. The news that 2/3rds of CFS patients taking a chemotherapy drug called Rituximab significantly improved in a rigorous, double-blinded placebo controlled trial swept the CFS community immediately and then medical websites.
Rituximab has been a kind of underground hope that’s slowly been getting stronger and stronger over time. Reports suggesting that Rituximab was helping, sometimes REALLY helping, in a small group of patients, began filtering out of Norway about a year and a half ago and Dr.… Read More
10 comments